The Largest Pharmaceutical Companies and Britain's Serious Fraud Office in the News

Oil-for-food: UK probe to cover more companies
A UK government probe into whether GlaxoSmithKline, AstraZeneca and Eli Lilly & Co bribed the Saddam Hussein administration in Iraq may expand to other...

British ask Lilly for data on Iraq sales
British fraud investigators are questioning Eli Lilly and Co. and at least two other drug makers about possible kickbacks they paid to trade...

UK pulls Glaxo into Iraq fraud probe
Serious Fraud Office has requested documents from GlaxoSmithKline as part of an investigation into kickbacks or bribes that may have...

Three UK drugs firms investigated over alleged Iraq bribes
THREE British pharmaceutical companies are under investigation by the Serious Fraud Office over alleged bribes paid to the former Iraqi...

Drug firms face grilling on 'Saddam bribes'
Executives from GlaxoSmithKline, AstraZeneca and Eli Lilly may be interviewed by Britain's Serious Fraud Office as part of its investigation into...

British Pharma Biggies Face Iraq Probe
Britain's largest pharmaceutical companies are facing questions about the controversial UN oil for food program in Iraq...

UK Probes Glaxo, AstraZeneca Over Iraqi Bribe Allegations
Drug makers GlaxoSmithKline PLC and AstraZeneca PLC have been asked to give documents to the United Kingdom's Serious Fraud...

UK drug firms told to hand over files in Iraq investigation
The Serious Fraud Office has ordered the British drug companies GlaxoSmithKline and AstraZeneca to hand over confidential emails and files relating to...

Lilly joins SFO 'bribes' list
American group Eli Lilly has become the third drug company to confirm a request from Britain's Serious Fraud Office to...

Probe into Iraqi drug contracts stepped up
GlaxoSmithKline and AstraZeneca, the pharmaceutical groups, have been ordered to release confidential documents to the Serious Fraud...

UK fraud regulator investigates 3 drug companies over bribes to Saddam
Britain's Serious Fraud Office has demanded documents from three major drug makers in connection with allegations that the companies paid bribes...

3rd British pharmaceutical company under suspicion of fraud
Eli Lilly has been asked to hand over documents as part of an investigation into alleged bribes paid to former Iraqi dictator Saddam Hussein...

Glaxo, AstraZeneca Get UK Document Request on Oil for Food
GlaxoSmithKline Plc, the world's second-largest drugmaker, and AstraZeneca Plc, the UK's No.2 pharmaceutical company...

Drug firms probed over Iraq cash
GlaxoSmithKline and AstraZeneca have been asked to hand over papers as part of a probe into bribes allegedly paid to Saddam Hussein's former Iraq regime...

UK fraud office demands drug firms' Iraq documents
GlaxoSmithKline Plc (GSK.L: Quote, Profile, Research) and AstraZeneca Plc (AZN.L: Quote, Profile, Research) said on Sunday Britain's...

UK fraud watchdog demands documents from GlaxoSmithKline and...
Britain's Serious Fraud Office has demanded documents from drug giants GlaxoSmithKline PLC and AstraZeneca PLC in connection with allegations...

Drug firms face Iraq bribes probe
Pharmaceutical companies GlaxoSmithKline and AstraZeneca have been asked to hand over documents to the Serious Fraud Office as part of its investigation...

SFO targets drug groups over UN scandal
Executives from GlaxoSmithKline (GSK), AstraZeneca and Eli Lilly could be interviewed by the Serious Fraud Office (SFO) as part of its investigation into...

Most Popular Now

AstraZeneca takes next steps towards broad and equ…

AstraZeneca has taken the next steps in its commitment to broad and equitable global access to the University of Oxford’s COVID-19 vaccine, following landmark agreements ...

Johnson & Johnson announces acceleration of it…

Johnson & Johnson (NYSE: JNJ) (the Company) today announced that through its Janssen Pharmaceutical Companies (Janssen) it has accelerated the initiation of the Phase 1/2...

Low-cost dexamethasone reduces death by up to one …

In March 2020, the RECOVERY (Randomised Evaluation of COVid-19 thERapY) trial was established as a randomised clinical trial to test a range of potential treatments for C...

Sanofi invests to make France its world class cent…

Sanofi detailed plans on how the Company will make significant investments in France to increase its vaccines research and production capacities, and contribute in respon...

Calquence showed promising clinical improvement in…

Results published in Science Immunology showed that Calquence (acalabrutinib), a Bruton’s tyrosine kinase (BTK) inhibitor, reduced markers of inflammation and improved cl...

Super-potent human antibodies protect against COVI…

A team led by Scripps Research has discovered antibodies in the blood of recovered COVID-19 patients that provide powerful protection against SARS-CoV-2, the coronavirus ...

New consortium EUbOPEN will provide tools to unloc…

Almost twenty years after deciphering the human genome, our understanding of human disease is still far from complete. One of the most powerful and versatile tools to bet...

AstraZeneca to supply Europe with up to 400 millio…

AstraZeneca has reached an agreement with Europe's Inclusive Vaccines Alliance (IVA), spearheaded by Germany, France, Italy and the Netherlands, to supply up to 400 milli...

Up to 45 percent of SARS-CoV-2 infections may be a…

An extraordinary percentage of people infected by the virus behind the ongoing deadly COVID-19 pandemic never show symptoms of the disease, according to the results of a ...

Researchers identify potent antibody cocktail to t…

Researchers at the University of Maryland School of Medicine (UMSOM) evaluated several human antibodies to determine the most potent combination to be mixed in a cocktail...

Gilead announces results from Phase 3 Trial of rem…

Gilead Sciences, Inc. (Nasdaq: GILD) announced topline results from the Phase 3 SIMPLE trial in hospitalized patients with moderate COVID-19 pneumonia. This open-label st...

Mayo finds convalescent plasma safe for diverse pa…

Mayo Clinic researchers and collaborators have found investigational convalescent plasma to be safe following transfusion in a diverse group of 20,000 patients. The findi...